<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urmj</journal-id><journal-title-group><journal-title xml:lang="ru">Уральский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Ural Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-4389</issn><publisher><publisher-name>Ural State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25694/URMJ.2019.03.17</article-id><article-id custom-type="elpub" pub-id-type="custom">urmj-505</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПСИХИАТРИЯ</subject></subj-group></article-categories><title-group><article-title>ПЭт/кт с 18F-FDG в уточняющей диагностике эпилепсии</article-title><trans-title-group xml:lang="en"><trans-title>Utility of 18F-FDG PET/CT in the diagnostics of Epilepsy</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аретинский</surname><given-names>Александр Витальевич</given-names></name><name name-style="western" xml:lang="en"><surname>Aretinskiy</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">are-tinskyi@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жиляков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhilyakov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аретинский</surname><given-names>В. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Aretinskiy</surname><given-names>V. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шершевер</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Shershever</surname><given-names>A. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Исупов</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Isupov</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шориков</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shorikov</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Центр ядерной медицины ООО «ПЭТ-Технолоджи»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>«Областной специализированный центр медицинской реабилитации “Озеро Чусовское”»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>ФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>14</day><month>04</month><year>2021</year></pub-date><volume>0</volume><issue>3</issue><fpage>25</fpage><lpage>29</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Аретинский А.В., Жиляков А.В., Аретинский В.Б., Шершевер А.С., Исупов А.Б., Шориков Е.В., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Аретинский А.В., Жиляков А.В., Аретинский В.Б., Шершевер А.С., Исупов А.Б., Шориков Е.В.</copyright-holder><copyright-holder xml:lang="en">Aretinskiy A.V., Zhilyakov A.V., Aretinskiy V.B., Shershever A.S., Isupov A.B., Shorikov E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.umjusmu.ru/jour/article/view/505">https://www.umjusmu.ru/jour/article/view/505</self-uri><abstract><p>Определение локализации эпилептогенных очагов при диагностике эпилепсии является важным шагом, направленным на выбор тактики и улучшение результатов лечения. В настоящее время для диагностики эпилепсии чаще всего применяется ЭЭГ (электроэнцефа-лография), магнитно-резонансная томография (МРТ) и, в меньшей степени, однофотонная эмиссионная компьютерная томография (ОФЭКТ). Чувствительность экстракраниальной ЭЭГ не превышает 56%, а при внутрикраниальном ЭЭГ высок риск осложнений. Несмотря на то что диагностическая ценность МРТ достаточно высока, у ряда пациентов (в особенности с фармакорезистентной эпилепсией) не удается выявить морфологические изменения. Одним из наиболее перспективных методов на сегодняшний день является диагностика с помощью позитронной эмиссионной томографии, совмещенной с компьютерной томогра-фией (ПЭТ/КТ), с использованием 18-фтордезоксиглюкозы (18F-FDG) в качестве радиотрей-сера. В данной статье систематизирован обзор литературы по данной проблеме за последние годы. Приводятся данные об информативности и диагностической ценности ПЭТ/КТ с 18F-FDG у пациентов с эпилепсией.</p></abstract><trans-abstract xml:lang="en"><p>Detecting the localization of epileptogenic focuses (seizure lateralization) in cases of epilepsy is an important diagnostic step aimed at choosing tactics and improving treatment outcomes. Currently, EEG (electroencephalography), magnetic resonance imaging (MRI) and, to a lesser extent, single photon emission computed tomography (SPECT) are most commonly used to diagnose epilepsy. The sensitivity of extracranial EEG does not exceed 56%, while at intracranial EEG the risk of complica-tions is high. Despite the fact that the diagnostic value of MRI is quite high, in a number of patients (especially with pharmacoresistant epilepsy), it is not possible to detect morphological changes. One of the most promising methods today is diagnostics using positron emission tomography, combined with computed tomography (PET/CT), using 18-fluorodeoxyglucose (18F-FDG) as a radiotracer. This article is a review of the literature on this issue in recent years. Data on informativity and diag-nostic value of PET / CT with 18F-FDG in patients with epilepsy are presented.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эпилепсия</kwd><kwd>позитронно эмиссионная томография</kwd><kwd>совмещенная с компьютерной томографией</kwd><kwd>18-фтордезоксиглюкоза</kwd><kwd>магнитно-резонансная томография (МРТ)</kwd><kwd>электроэнцефалография (ЭЭГ)</kwd><kwd>epilepsy</kwd><kwd>positron emission tomography/computed tomography</kwd><kwd>18F-fluoro-2-deoxy-D-glucose</kwd><kwd>magnetic resonance imaging (MRI)</kwd><kwd>electroencephalography (EEG)</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Marina Hodolic, Raffi Topakian, Robert Pichler. 18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy. Radiology and Oncology. Volume 50, Issue 3. 2016; 247-253</mixed-citation><mixed-citation xml:lang="en">Marina Hodolic, Raffi Topakian, Robert Pichler. 18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy. Radiology and Oncology. Volume 50, Issue 3. 2016; 247-253</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ismet Sarikaya. PET studies in epilepsy. Am J Nucl Med Mol Imaging. 2015; 5(5): 416-430</mixed-citation><mixed-citation xml:lang="en">Ismet Sarikaya. PET studies in epilepsy. Am J Nucl Med Mol Imaging. 2015; 5(5): 416-430</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Devous MD Sr, Thisted RA, Morgan GF, Leroy RF, Rowe CC. SPECT brain imaging in epilepsy: a metaanalysis. J Nucl Med. 1999; 285-293</mixed-citation><mixed-citation xml:lang="en">Devous MD Sr, Thisted RA, Morgan GF, Leroy RF, Rowe CC. SPECT brain imaging in epilepsy: a metaanalysis. J Nucl Med. 1999; 285-293</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Аретинский А.В., Терновой С.К. ПЭТ/КТ с 18F-FDG в уточняющей диагностике рака тела матки. REJR 2018; 8(3): 20-29.</mixed-citation><mixed-citation xml:lang="en">Аретинский А.В., Терновой С.К. ПЭТ/КТ с 18F-FDG в уточняющей диагностике рака тела матки. REJR 2018; 8(3): 20-29.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Society of Nuclear Medicine Procedure Guideline for FDG PET Brain Imaging Version 1.0. approved February 8, 2009; 1-11.</mixed-citation><mixed-citation xml:lang="en">Society of Nuclear Medicine Procedure Guideline for FDG PET Brain Imaging Version 1.0. approved February 8, 2009; 1-11.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Franck Semah, Gregory Petyt. Clinical applications of PET/CT in neurology. Principles and Practice of PET/ CT. 2017; 159-161</mixed-citation><mixed-citation xml:lang="en">Franck Semah, Gregory Petyt. Clinical applications of PET/CT in neurology. Principles and Practice of PET/ CT. 2017; 159-161</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Stanescu L, Ishak GE, Khanna PC, Biyyam DR, Shaw DW, Parisi MT. FDG PET of the brain in pediatric patients: imaging spectrum with MR imaging correlation. Radiographics. 2013;1279-1303</mixed-citation><mixed-citation xml:lang="en">Stanescu L, Ishak GE, Khanna PC, Biyyam DR, Shaw DW, Parisi MT. FDG PET of the brain in pediatric patients: imaging spectrum with MR imaging correlation. Radiographics. 2013;1279-1303</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chugani HT, Phelps ME. Imaging human brain development with positron emission tomography. J Nucl Med. 1991;23-26</mixed-citation><mixed-citation xml:lang="en">Chugani HT, Phelps ME. Imaging human brain development with positron emission tomography. J Nucl Med. 1991;23-26</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002; 302-316</mixed-citation><mixed-citation xml:lang="en">Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002; 302-316</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Won HJ, Chang KH, Cheon JE, Kim HD, Lee DS, Han MH, et al. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. AJNR Am J Neuroradiol. 1999; 593-599</mixed-citation><mixed-citation xml:lang="en">Won HJ, Chang KH, Cheon JE, Kim HD, Lee DS, Han MH, et al. Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. AJNR Am J Neuroradiol. 1999; 593-599</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kim YK, Lee DS, Lee SK, Chung CK, Chung JK, Lee MC. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med. 2002; 1167-74</mixed-citation><mixed-citation xml:lang="en">Kim YK, Lee DS, Lee SK, Chung CK, Chung JK, Lee MC. (18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med. 2002; 1167-74</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gok B, Jallo G, Hayeri R, Wahl R, Aygun N. The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy. Neuroradiology. 2013; 541-50</mixed-citation><mixed-citation xml:lang="en">Gok B, Jallo G, Hayeri R, Wahl R, Aygun N. The evaluation of FDG-PET imaging for epileptogenic focus localization in patients with MRI positive and MRI negative temporal lobe epilepsy. Neuroradiology. 2013; 541-50</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rathore C, Dickson JC, Teotonio R, Ell P, Duncan JS. The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res. 2014;1306-1314</mixed-citation><mixed-citation xml:lang="en">Rathore C, Dickson JC, Teotonio R, Ell P, Duncan JS. The utility of 18F-fluorodeoxyglucose PET (FDG PET) in epilepsy surgery. Epilepsy Res. 2014;1306-1314</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Da Silva EA, Chugani DC, Muzik O, Chugani HT. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia. 1997,2006; 1198-1208</mixed-citation><mixed-citation xml:lang="en">Da Silva EA, Chugani DC, Muzik O, Chugani HT. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia. 1997,2006; 1198-1208</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Buch K, Blumenfeld H, Spencer S, Novotny E, Zubal IG. Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization. Eur J Nucl Med Mol Imaging. 2008; 579-588</mixed-citation><mixed-citation xml:lang="en">Buch K, Blumenfeld H, Spencer S, Novotny E, Zubal IG. Evaluating the accuracy of perfusion/metabolism (SPET/PET) ratio in seizure localization. Eur J Nucl Med Mol Imaging. 2008; 579-588</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hassan Kassema, Fahd El Shiekhb, Ahmed Wafaiec, Sherif Abdelfattahc, Hussein Farghalyd, Lamia Afifie. Presurgical evaluation of refractory temporal lobe epilepsy: Comparison of MR imaging, PET and ictal SPECT in localization of the epileptogenic substrate. The Egyptian Journal of Radiology and Nuclear Medicine Volume 44, Issue 3, 2013; 641-649</mixed-citation><mixed-citation xml:lang="en">Hassan Kassema, Fahd El Shiekhb, Ahmed Wafaiec, Sherif Abdelfattahc, Hussein Farghalyd, Lamia Afifie. Presurgical evaluation of refractory temporal lobe epilepsy: Comparison of MR imaging, PET and ictal SPECT in localization of the epileptogenic substrate. The Egyptian Journal of Radiology and Nuclear Medicine Volume 44, Issue 3, 2013; 641-649</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Masaki Iwasaki, Kazutaka Jin, Nobukazu Nakasato, Teiji Tominaga. Non-invasive Evaluation for Epilepsy Surgery. Neurol Med Chir (Tokyo). 2016; 632-640</mixed-citation><mixed-citation xml:lang="en">Masaki Iwasaki, Kazutaka Jin, Nobukazu Nakasato, Teiji Tominaga. Non-invasive Evaluation for Epilepsy Surgery. Neurol Med Chir (Tokyo). 2016; 632-640</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gokdemir S1, Halac M, Albayram S, Oz B, Yeni N, Uzan M, Ozkara C. Contribution of FDG-PET in epilepsy surgery: consistency and postoperative results compared with magnetic resonance imaging and electroencephalography. Turk Neurosurg. 2015; 53-57</mixed-citation><mixed-citation xml:lang="en">Gokdemir S1, Halac M, Albayram S, Oz B, Yeni N, Uzan M, Ozkara C. Contribution of FDG-PET in epilepsy surgery: consistency and postoperative results compared with magnetic resonance imaging and electroencephalography. Turk Neurosurg. 2015; 53-57</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Willmann O, Wennberg R, May T, Woermann FG, Pohlmann-Eden B. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy A meta-analysis. Seizure. 2007; 509-520</mixed-citation><mixed-citation xml:lang="en">Willmann O, Wennberg R, May T, Woermann FG, Pohlmann-Eden B. The contribution of 18F-FDG PET in preoperative epilepsy surgery evaluation for patients with temporal lobe epilepsy A meta-analysis. Seizure. 2007; 509-520</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Leiderman DB, Albert P, Balish M, Bromfield E, Theodore WH. The dynamics of metabolic change following seizures as measured by positron emission tomography with fludeoxyglucose F 18. Arch Neurol. 1994; 932-936</mixed-citation><mixed-citation xml:lang="en">Leiderman DB, Albert P, Balish M, Bromfield E, Theodore WH. The dynamics of metabolic change following seizures as measured by positron emission tomography with fludeoxyglucose F 18. Arch Neurol. 1994; 932-936</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, et al. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur J Nucl Med Mol Imaging. 2003; 581-587</mixed-citation><mixed-citation xml:lang="en">Choi JY, Kim SJ, Hong SB, Seo DW, Hong SC, Kim BT, et al. Extratemporal hypometabolism on FDG PET in temporal lobe epilepsy as a predictor of seizure outcome after temporal lobectomy. Eur J Nucl Med Mol Imaging. 2003; 581-587</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
